GenTech Scientific: Your trusted provider since 1996 for quality refurbished analytical instrument (GC, MS & LC) sales, service, parts, training, and rentals.
A discussion with Morgan Keefer, a Board Member for the Institute of Cannabis Science, and an experienced cannabis testing laboratory accreditation professional.
#cannabistesting#consumersafetyhubs.la/Q04kz6R00
This week's featured eBay item is a Waters Micromass ZSpray LockSpray Ion Source with ESI Head. This source supports three ionization modes - ESI, APCI, ESCi - making it highly versatile in addition to providing excellent mass accuracy.
#watersxevo#ionsource
"The HbA1c reduction is similar to that of dual GLP-1 and GIP agonists...For example, tirzepatide (Mounjaro) was associated with a 1.5% reduction in HbA1c when used as a standalone therapy in a trial."
#diabetes2#weightreduction#A1c#GLP1#GIP#glucagonhubs.la/Q04kvXZT0
"The full-spectrum cannabis extract is meant to ease chronic lower back pain, serving as an alternative to opioids, which carry significant abuse risk and side effects."
#medicalcannabis#plantmedicinehubs.la/Q04ky5G40
"The word "instrument" is a fantastic overlap in language, I find, because both medical and musical instruments are really about extending human capability."
hubs.la/Q04jQdly0#research#AI#stroke
This week's eBay featured item is a genuine Thermo Orbitrap Power Supply Assembly (PN: 2099810-02). This power supply regulates the high-voltage and low-voltage outputs necessary for your mass spectrometer’s ion optics and internal components.
hubs.la/Q04jPwlW0
Happy Dinosaur Day! Some things never go extinct — and the Agilent 5890 GC is proof. At Gentech Scientific, we keep these legends alive with refurbished units, parts & service. #DinosaurDay#Agilent5890#GentechScientific
Linking PFAS to human health: Free, on demand webinar.
Explores the connection between environmental PFAS exposure and heart disease risk in postmenopausal women.
#foreverchemicals#pfas#heartdiseasehubs.la/Q04j4PD40
A long term follow-up study of patients in an earlier Phase I/II trial showed a 27.5% drop in risk for death or liver transplant in those who received the therapy versus usual care over up to four years of follow up.
#cirrhosis#celltherapyhubs.la/Q04hYTnN0